Treating asthma in the COVID-19 pandemic

[...]ciclesonide has been found to suppress the replication of SARS-CoV-2 through interaction with viral NSP15 during biogenesis, and fluticasone propionate has been identified as a potential therapeutic candidate in COVID-19.14 15 The use of ICS in asthma has been associated with decreased expressi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thorax 2020-10, Vol.75 (10), p.822-823
Hauptverfasser:	Wang, Ran, Bikov, Andras, Fowler, Stephen J
Format:	Artikel
Sprache:	eng
Schlagworte:	Asthma Betacoronavirus Chronic obstructive pulmonary disease Coronavirus Infections Coronaviruses COVID-19 Cytokines Disease Editorial Hospitals Humans Infections Mortality Pandemics Patient compliance Pneumonia Pneumonia, Viral SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Viral infections
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!